Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Construction in Progress of $66.2 million in Q1 2016, up 5.04% quarter-over-quarter from $63.0 million in Q4 2015, and up 33.85% on a YoY basis from $49.4 million in Q2 2015.
Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $66.2 million for Q1 2016.
- In Q1 2016, Construction in Progress rose 33.85% year-over-year to $66.2 million; the TTM figure through Mar 2016 stood at $66.2 million (up 33.85% YoY), while the FY2015 annual figure was $63.0 million, up 69.63% from the prior year.
- Construction in Progress was $66.2 million for Q1 2016 at Jazz Pharmaceuticals, up from $63.0 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $66.2 million in Q1 2016 to a low of $148000.0 in Q1 2012.
- Historically, Construction in Progress has averaged $24.0 million across 5 years, with a median of $10.6 million in 2014.
- The sharpest annual moves came in 2013 and 2016: Construction in Progress jumped 1239.19% in 2013, then jumped 33.85% in 2016.
- A 5-year view of Construction in Progress shows it stood at $1.1 million in 2012, then surged by 286.61% to $4.4 million in 2013, then surged by 746.51% to $37.1 million in 2014, then jumped by 69.63% to $63.0 million in 2015, then gained by 5.04% to $66.2 million in 2016.
- The last three Construction in Progress figures came in at $66.2 million (Q1 2016), $63.0 million (Q4 2015), and $61.1 million (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 66.19 Mn |
| Dec 31, 2015 | 63.01 Mn |
| Sep 30, 2015 | 61.06 Mn |
| Jun 30, 2015 | 57.88 Mn |
| Mar 31, 2015 | 49.45 Mn |
| Dec 31, 2014 | 37.15 Mn |
| Sep 30, 2014 | 24.25 Mn |
| Jun 30, 2014 | 18.04 Mn |
| Mar 31, 2014 | 10.64 Mn |
| Dec 31, 2013 | 4.39 Mn |
| Sep 30, 2013 | 5.06 Mn |
| Jun 30, 2013 | 4.20 Mn |
| Mar 31, 2013 | 1.98 Mn |
| Dec 31, 2012 | 1.14 Mn |
| Sep 30, 2012 | 1.05 Mn |
| Jun 30, 2012 | 2.46 Mn |
| Mar 31, 2012 | 148,000.00 |
| Dec 31, 2011 | 689,000.00 |
| Dec 31, 2010 | 73,000.00 |